Enhancing Patient Care & Outcomes in the Infectious Disease Setting with Clinically-Integrated Health System Specialty Pharmacy Services

Note: If you attended the live CE activity AND received CE credit (i.e. a pharmacist or pharmacy technician CE statement of credit with ACPE UAN 0221-9999-20-359-L04-P/T), you are NOT allowed to also receive credit for this home-study on-demand web activity.

Activity Description

Patients living with HIV, Hepatitis C and other infectious diseases sometimes require specialty medications to manage or treat their conditions. These medications are often difficult for patients to afford and often cause challenging side effects. Without appropriate support from their pharmacy, patients may struggle to adhere to their therapy regimens, resulting in subpar clinical outcomes.

The clinically-integrated health system specialty pharmacy care model has proven effective at ensuring patients receive the coordinated, high-touch care needed to improve adherence and enhance outcomes. During this webinar, a pharmacist, pharmacy liaison and provider from Summa Health’s Care Center will share:

  • Why clinically-integrated health system specialty pharmacies are uniquely positioned to address the needs of patients in the infectious disease setting
  • How embedded pharmacists and pharmacy liaisons add value to an infectious disease care team
  • What steps a health system specialty pharmacy can take to begin leverage data to enhance care and outcomes for patients living with HIV

Learning Objectives

The target audience for this activity is pharmacists and pharmacy technicians. Upon completion of this activity, participants will be able to:

  • Compare the clinically-integrated specialty pharmacy services care model to other approaches.
  • Explain the roles of an embedded pharmacist and pharmacy liaison on the care team.
  • List metrics that health system specialty pharmacies can track in the infectious disease setting.
  • Discuss how the clinically-integrated care model benefits patients and providers in the infectious diseases setting.


Amy Hite, MD, Director of Summa Health’s CARE Center

Kyle Snoke, PharmD, AAHIVP, Clinical Pharmacist in Summa Health’s CARE Center (Trellis Rx)

Samantha Goff, CPhT, Specialty Pharmacy Liaison in Summa Health’s CARE Center

CE Accreditation

Release Date: September 9, 2020
Expiration Date: September 9, 2021

Pharmacists and Pharmacy Technicians

This activity is jointly provided by ProCE, Inc. and Trellis Rx. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-359-H04-P/T has been assigned to this home study knowledge-based activity. This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Ms. Samantha Goff and Dr. Kyle Snoke have no relevant commercial or financial relationships to disclose. Dr. Amy Hite is a speaker for Gilead Sciences and Janssen Pharmaceuticals, and is an advisory board member for ViiV.


No external support has been received for this activity.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.